187 related articles for article (PubMed ID: 24022491)
1. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.
Woods NK; Padmanabhan J
J Biol Chem; 2013 Oct; 288(42):30114-30124. PubMed ID: 24022491
[TBL] [Abstract][Full Text] [Related]
2. Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.
Milosch N; Tanriöver G; Kundu A; Rami A; François JC; Baumkötter F; Weyer SW; Samanta A; Jäschke A; Brod F; Buchholz CJ; Kins S; Behl C; Müller UC; Kögel D
Cell Death Dis; 2014 Aug; 5(8):e1391. PubMed ID: 25165877
[TBL] [Abstract][Full Text] [Related]
3. The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.
Delarasse C; Auger R; Gonnord P; Fontaine B; Kanellopoulos JM
J Biol Chem; 2011 Jan; 286(4):2596-606. PubMed ID: 21081501
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
5. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
[TBL] [Abstract][Full Text] [Related]
6. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
Carey RM; Blusztajn JK; Slack BE
BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
[TBL] [Abstract][Full Text] [Related]
7. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.
Colombo A; Wang H; Kuhn PH; Page R; Kremmer E; Dempsey PJ; Crawford HC; Lichtenthaler SF
Neurobiol Dis; 2013 Jan; 49():137-47. PubMed ID: 22940630
[TBL] [Abstract][Full Text] [Related]
8. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage of amyloid precursor protein by ADAM10 promotes proliferation and migration via activating MAPKs pathway in tongue squamous cell carcinoma in vitro.
Hong Y; Wei Z; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):167-173. PubMed ID: 38158671
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
[TBL] [Abstract][Full Text] [Related]
11. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
13. Improved synthesis of ADAM10 inhibitor GI254023X.
Hoettecke N; Ludwig A; Foro S; Schmidt B
Neurodegener Dis; 2010; 7(4):232-8. PubMed ID: 20197648
[TBL] [Abstract][Full Text] [Related]
14. Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Kato N; Araseki M; Nishimura M; Hartmann D; Saftig P; Fahrenholz F; Taniguchi M; Urakami K; Akatsu H; Martins RN; Yamamoto K; Maeda M; Yamamoto T; Nakaya T; Gandy S; Suzuki T
J Biol Chem; 2009 Dec; 284(52):36024-36033. PubMed ID: 19864413
[TBL] [Abstract][Full Text] [Related]
15. Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.
Pupovac A; Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2015 Jan; 93(1):77-85. PubMed ID: 25155463
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein.
Lin X; Huang M; Xie F; Zhou H; Yang J; Huang Q
Oncotarget; 2016 Oct; 7(43):70092-70099. PubMed ID: 27602753
[TBL] [Abstract][Full Text] [Related]
17. Soluble amyloid precursor protein: a novel proliferation factor of adult progenitor cells of ectodermal and mesodermal origin.
Demars MP; Bartholomew A; Strakova Z; Lazarov O
Stem Cell Res Ther; 2011 Aug; 2(4):36. PubMed ID: 21878106
[TBL] [Abstract][Full Text] [Related]
18. ADAM10: a new player in breast cancer progression?
Mullooly M; McGowan PM; Kennedy SA; Madden SF; Crown J; O' Donovan N; Duffy MJ
Br J Cancer; 2015 Sep; 113(6):945-51. PubMed ID: 26284334
[TBL] [Abstract][Full Text] [Related]
19. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
[TBL] [Abstract][Full Text] [Related]
20. Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production.
Tian Y; Crump CJ; Li YM
J Biol Chem; 2010 Oct; 285(42):32549-56. PubMed ID: 20675367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
